Effects of ibrutinib treatment on murine platelet function during inflammation and in primary hemostasis

Haematologica

Volumn 102, Issue 3, 2017, Pages e89-e92

  Lee, Robert H ^a   Piatt, Raymond ^a   Conley, Pamela B ^b   Bergmeier, Wolfgang ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Portola Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CONVULXIN; G PROTEIN COUPLED RECEPTOR; IBRUTINIB; PODOPLANIN; ADENOSINE DIPHOSPHATE; ALANYL-TYROSYL-PROLYL-GLYCYL-LYSYL-PHENYLALANINE; CLEC-2 PROTEIN, MOUSE; COLLAGEN; FIBRINOGEN RECEPTOR; GP38 PROTEIN, MOUSE; LECTIN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; OLIGOPEPTIDE; P2RY12 PROTEIN, MOUSE; PLATELET MEMBRANE GLYCOPROTEIN VI; PROTEIN KINASE INHIBITOR; PURINERGIC P2Y12 RECEPTOR; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; SNAKE VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHUS PHENOMENON; BLEEDING TIME; BRONCHOALVEOLAR LAVAGE FLUID; CONTROLLED STUDY; EXPERIMENTAL PNEUMONIA; HEMOSTASIS; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; INFLAMMATION; LETTER; LIPOPOLYSACCHARIDE-INDUCED AIRWAY INFLAMMATION; MOUSE; NONHUMAN; PROTEIN ANALYSIS; SKIN BIOPSY; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; AGONISTS; ANIMAL; BLEEDING; CYTOLOGY; DEFICIENCY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LUNG; METABOLISM; PATHOLOGY; SKIN; THROMBOCYTE;

ADENOSINE DIPHOSPHATE; ANIMALS; BLOOD PLATELETS; COLLAGEN; CROTALID VENOMS; GENE EXPRESSION REGULATION; HEMORRHAGE; HEMOSTASIS; INFLAMMATION; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; LUNG; MEMBRANE GLYCOPROTEINS; MICE; OLIGOPEPTIDES; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIMIDINES; RECEPTORS, PURINERGIC P2Y12; SKIN;

EID: 85014491158     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2016.155978     Document Type: Letter

References (15)

1. Lipsky AH, Farooqui MZ, Tian X, et al. Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib. Haematologica. 2015;100(12):1571-1578.
2. Byrd JC, Brown JR, O'Brien S, et al. Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia. N Engl J Med. 2014;371(3):213-223.
3. Winqvist M, Asklid A, Andersson PO, et al. Real--world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: Data from 95 consecutive patients treated in a compassionate use program. Haematologica. 2016;101(12):1573-1580.
4. Manne BK, Badolia R, Dangelmaier C, et al. Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets. J Biol Chem. 2015;290(18):11557-11568.
5. Bye AP, Unsworth AJ, Vaiyapuri S, Stainer AR, Fry MJ, Gibbins JM. Ibrutinib Inhibits Platelet Integrin alphaIIbbeta3 Outside-In Signaling and Thrombus Stability But Not Adhesion to Collagen. Arterioscler Thromb Vasc Biol. 2015;35(11):2326-2335.
6. Levade M, David E, Garcia C, et al. Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions. Blood. 2014;124(26):3991-3995.
7. Kamel S, Horton L, Ysebaert L, et al. Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation. Leukemia. 2015;29(4):783-787.
8. Rigg RA, Aslan JE, Healy LD, et al. Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function. Am J Physiol Cell Physiol. 2016;310(5):C373-380.
9. Goerge T, Ho-Tin-Noe B, Carbo C, et al. Inflammation induces hemorrhage in thrombocytopenia. Blood. 2008;111(10):4958-4964.
10. Boulaftali Y, Hess PR, Getz TM, et al. Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest. 2013;123(2):908-916.
11. Getz TM, Piatt R, Petrich BG, Monroe D, Mackman N, Bergmeier W. Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition. J Thromb Haemost. 2014;13(3):417-425.
12. Andre P, Delaney SM, LaRocca T, et al. P2Y12 regulates platelet adhesion/ activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest. 2003;112(3):398-406.
13. Gros A, Syvannarath V, Lamrani L, et al. Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex-mediated inflammation in mice. Blood. 2015;126(8):1017-1026.
14. Nonne C, Lenain N, Hechler B, et al. Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity. Arterioscler Thromb Vasc Biol. 2005;25(6):1293-1298.
15. Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol. 1995;35(3):209-219.